Provigil Likely To Add Two New Claims; Broad Sleepiness Indication May Wait

Cephalon expects that Provigil (modafinil) will receive an "approvable" letter on Oct. 20 for use in sleep disruption and circadian misalignment, CEO Frank Baldino said during a Sept. 25 conference call following an advisory committee review of expanded labeling for the narcolepsy agent